Ryan D. Maynard
2012
In 2012, Ryan D. Maynard earned a total compensation of $1.5M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 48% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,550 |
|---|---|
| Option Awards | $827,130 |
| Salary | $426,420 |
| Other | $780 |
| Total | $1,456,880 |
Maynard received $827.1K in option awards, accounting for 57% of the total pay in 2012.
Maynard also received $202.6K in non-equity incentive plan, $426.4K in salary and $780 in other compensation.
Rankings
In 2012, Ryan D. Maynard's compensation ranked 4,670th out of 11,487 executives tracked by ExecPay. In other words, Maynard earned more than 59.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,670 out of 11,487 | 59th |
Division Manufacturing | 1,630 out of 4,253 | 62nd |
Major group Chemicals And Allied Products | 374 out of 1,203 | 69th |
Industry group Drugs | 235 out of 925 | 75th |
Industry Pharmaceutical Preparations | 183 out of 700 | 74th |
Source: SEC filing on March 30, 2015.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2012.
2012
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2012
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2012
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2012
Elliott Grossbard
Rigel Pharmaceuticals